📰 Neil Kumar News
Page 6 - Neil Kumar News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Neil Kumar. Real-time updates on events, politics, business and more.
April 22, 2023
BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Rating) was the target of a significant drop in short interest in March. As of March 31st, there was short interest totalling 15,160,000 shares, a drop of 13.5% from the March 15th total of 17,520,000 shares. Currently, 13.4% of the company’s stock are short sold. Based on an average […]
April 21, 2023
Peter Brimelow writes: For various reasons, I ha...
April 21, 2023
Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Rating) were down 5.3% on Friday . The stock traded as low as $15.52 and last traded at $15.59. Approximately 965,829 shares were traded during mid-day trading, a decline of 67% from the average daily volume of 2,905,068 shares. The stock had previously closed at $16.47. Analyst […]
April 21, 2023
Should You Buy or Sell BridgeBio Pharma Stock? Get The Latest BBIO Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.
April 19, 2023
BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Rating)’s share price gapped up prior to trading on Wednesday . The stock had previously closed at $15.15, but opened at $16.19. BridgeBio Pharma shares last traded at $15.78, with a volume of 355,107 shares trading hands. Analysts Set New Price Targets A number of equities research analysts have […]
April 13, 2023
BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Rating)’s share price gapped up before the market opened on Thursday after SVB Securities raised their price target on the stock from $25.00 to $27.00. The stock had previously closed at $15.18, but opened at $15.58. BridgeBio Pharma shares last traded at $15.87, with a volume of 112,369 shares. […]
April 13, 2023
BridgeBio Pharma (NASDAQ:BBIO – Get Rating) had its price target hoisted by analysts at SVB Securities from $25.00 to $27.00 in a research note issued on Thursday, The Fly reports. SVB Securities’ target price points to a potential upside of 77.87% from the stock’s current price. Several other equities research analysts also recently commented on […]
April 10, 2023
BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Rating) CEO Neil Kumar sold 120,000 shares of the firm’s stock in a transaction that occurred on Wednesday, April 5th. The shares were sold at an average price of $15.46, for a total transaction of $1,855,200.00. Following the completion of the transaction, the chief executive officer now directly owns […]
April 10, 2023
BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Rating) CFO Brian C. Stephenson sold 55,500 shares of BridgeBio Pharma stock in a transaction that occurred on Wednesday, April 5th. The stock was sold at an average price of $15.45, for a total value of $857,475.00. Following the completion of the transaction, the chief financial officer now directly […]
April 10, 2023
BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Rating) CFO Brian C. Stephenson sold 55,500 shares of BridgeBio Pharma stock in a transaction dated Wednesday, April 5th. The stock was sold at an average price of $15.45, for a total value of $857,475.00. Following the completion of the transaction, the chief financial officer now owns 101,337 shares […]